U.S. Construction Stock News

American Water Works Company stock is coming off a disappointing run over the past five years, yet the current checks suggest the shares are not obviously cheap, with the Dividend Discount Model (DDM) pointing to a premium to the intrinsic value estimate while broader metrics signal pricing that looks roughly in line with the market. Shareholders have seen the stock decline 16.5% over the past five years, which raises questions about how much of American Water Works Company's quality is...

Crocs, Inc. reported second-quarter 2026 results showing sales of US$1,179.47 million and net income of US$204.89 million, marking a return to profitability for both the quarter and first half after losses a year earlier. The company also raised its full-year 2026 revenue and earnings guidance while continuing substantial share repurchases, signalling management’s confidence in the business outlook and capital allocation approach. Next, we’ll examine how Crocs’ return to profitability and...

In August 2026, Kimco Realty Corporation reported higher quarterly and year-to-date revenue but mixed net income trends, while also issuing US$600.0 million of 3.50% exchangeable senior notes due 2031 and completing a US$95.26 million share repurchase program covering 0.53% of shares. The company simultaneously raised its full-year 2026 net income guidance to US$1.00–US$1.03 per diluted share, approved a 12.0% increase in its quarterly common dividend to US$0.28 per share, and declared...

Aura Minerals Inc. recently reported second-quarter 2026 results showing sales of US$335.97 million and net income of US$217.69 million, alongside a Board-approved dividend of US$0.72 per share (around US$60.42 million) paid on August 28, 2026 to shareholders of record on August 18, 2026. The company also reaffirmed its full-year 2026 production guidance while issuing second-half output expectations, underlining management’s confidence in operational performance and cash generation to...

Walt Disney (NYSE:DIS) has appointed former HBO Max architect Andy Shu as Head of Commerce for Disney+ Asia Pacific. Shu previously played a key role in scaling Warner Bros. Discovery's HBO Max offering across the Asia Pacific region. The new role focuses on growing engagement and monetization within Disney+ across key Asia Pacific markets. The appointment signals Disney's interest in closer integration of commerce and digital experiences across its streaming platform in the region. This...

DPC Holdings stock slipped 2.9% to about US$52 in the first full session after earnings, even though the headlines read like a company hitting its stride. Revenue for Q2 reached US$268.7m and management now pegs full year 2026 sales in a US$1.00b to US$1.04b range, backed by record adjusted earnings before interest, tax, depreciation and amortisation. That tension between a soft one day move and a stronger multi quarter build in the income statement is the real story. The next sections unpack...

CareTrust REIT has delivered a strong 131.3% total return over the past 5 years, yet the current valuation checks and recent share price pullback invite a closer look at whether the stock still offers good value after that run. Over 5 years, a 131.3% return places CareTrust REIT among the stronger performers, which can reduce the margin of safety if earnings and cash flow do not keep pace. The recent announcement of US$291 million in new investments and a US$1.5b year to date total may...

Why STAAR Surgical’s Latest Earnings Are Getting Fresh Attention STAAR Surgical (STAA) has returned to profitability in its latest report, which is a key reason the stock is back in focus for many investors this week. See our latest analysis for STAAR Surgical. STAAR Surgical’s latest earnings and leadership changes have arrived alongside a mixed price picture, with a 7.67% year to date share price return contrasting with a 5 year total shareholder return that is down 82.32%. This suggests...

DICK'S Sporting Goods stock has delivered a strong 123.7% return over the past 5 years, yet on today's numbers it screens as roughly in line with fair value rather than a clear bargain or an obvious excess. Recent short term weakness and a mixed set of valuation checks mean investors now have to weigh solid long term gains against a more balanced pricing picture. Over 5 years, DICK'S Sporting Goods has returned 123.7%, which suggests long term holders have already captured a substantial...

Chipotle Mexican Grill (NYSE: CMG) has relaunched its Chipotle IQ interactive trivia campaign for loyalty members in the U.S. and Canada. The latest Chipotle IQ round adds new reward mechanics, physical game sweepstakes, and daily streak features for participants. The campaign continues to highlight Chipotle's focus on customer engagement and loyalty program incentives. For investors watching how consumer brands use promotions to strengthen loyalty and potential future sales, it can be...

SailPoint (SAIL) has drawn fresh attention after a recent special call, followed closely by the launch of its Identity Security solution, which targets both human and non-human identities in increasingly complex AI driven environments. See our latest analysis for SailPoint. The recent Identity Security launch and special call appear to sit alongside a sharp shift in sentiment. SailPoint’s 30 day share price return of 33.69% and 90 day share price return of 42.11% contrast with a year to date...

Western Union (NYSE:WU) has launched Stablecard, a digital wallet and Visa-backed credit card built around the USDPT stablecoin for cross-border payments and money transfers. The new product uses blockchain infrastructure to support global transactions and everyday spending for users who hold USDPT. Stablecard is designed to appeal to customers in markets with unstable local currencies by offering a dollar-linked digital balance for remittances and payments. The launch extends Western...

Protalix BioTherapeutics shares jumped 7.8% to US$2.62 into the close, and that move captures only part of the story. The stock came into this print already on a strong run over the past three months. Today’s reaction, however, appears to lean more on emotion than on new information. The focus is on margin and profitability. Q2 net income reached US$3.8m with earnings per share of US$0.05, supported by US$19.9m in revenue and a cash balance of about US$40.7m with no debt. The market appears...

CAVA Group stock just ripped 14.3% in a single session, yet the real story sits in the income statement, not the ticker tape. You are watching a high expectation stock with a rich 131.3x trailing P/E trade as if Q2 settled a lot of doubts in one go. The headline is simple: Strong Q2 restaurant performance and 9% same restaurant sales growth landed on top of a business that still runs on a slim 4.8% trailing net margin. The move looks like the market rewarding momentum while largely setting...

CoreWeave went into this print with a hot growth story and a stock that had already run hard. Then the earnings drop hit and the market punched the accelerator. The share price jumped about 19% to US$107.73, a sharp move for a company already priced on high expectations. The reason sits squarely in the top line and in operating leverage. Revenue for the quarter landed at US$2.6b and adjusted earnings before interest, tax, depreciation and amortisation margin reached 59%. For an AI...

Cooling inflation and a less aggressive Federal Reserve are quietly reshaping the backdrop for U.S. consumer discretionary and retail stocks. With headline CPI at 3.4% and core inflation at 2.5%, real purchasing power may be starting to breathe again, which could matter a lot for select retailers and brands. This article walks through three stocks exposed to this macro turn and why they might deserve a closer look right now. The stocks covered below are just a starting sample, and the full...

Nurix Therapeutics recently reported earning a US$10 million milestone payment from Sanofi for advancing its oral STAT6 degrader into a Phase 1 trial, while also enrolling the first patient in a global Phase 3 study of its BTK degrader bexobrutideg in partnership with Roche for relapsed or refractory CLL/SLL. Together, these updates highlight how Nurix’s DEL-AI protein degradation platform is now translating into late-stage clinical programs and tangible partnership revenues under its Sanofi...

DuPont de Nemours (NYSE: DD) has been selected to supply its MemCor membrane bioreactor system for the upgrade of the Lower Molonglo Water Quality Control Centre in Australia. The facility is the largest inland wastewater treatment plant in the country and is being upgraded to support population growth and more resilient water infrastructure. The project highlights DuPont's Water Solutions business and its role in advanced treatment technologies for global water infrastructure. This kind of...

In early August 2026, Netlist, Inc. announced it had entered into a five-year alliance with Samsung covering a patent portfolio cross-license, memory product supply, technology cooperation, and the settlement of all pending legal actions, with Samsung also agreeing to purchase 10 million Netlist shares. This agreement gives Samsung access to Netlist’s full server DIMM and High Bandwidth Memory patent portfolio while securing DRAM and NAND supply for Netlist, marking a material shift in...

Cooling inflation, softer rate expectations and cheaper fuel have shifted the ground for smaller U.S. consumer and travel stocks, but not all in the same way. Some companies may see a little more room on pricing and margins, while others could feel the pinch from still sticky shelter costs. This article walks through three stocks from a small-cap screener that appear positively exposed to this latest CPI backdrop. The stocks highlighted below are only a starting sample from this idea, and the...

Aquestive Therapeutics stock slipped about 4% today, even though the headline from Q2 is more about balance sheet breathing room than a collapse in the story. The company ended the quarter with US$98.5m in cash and reaffirmed full year 2026 guidance for revenue in the US$46m to US$50m range and a non GAAP adjusted EBITDA loss of US$35m to US$30m. For a small biopharma stock that trades on belief in future products, that mix of liquidity, steady guidance and ongoing losses is what is really...

CI&T stock barely flinched after Q2, slipping just 0.6% to US$3.62, even as the company posted another quarter of double digit organic revenue growth and lifted full year guidance. Short term traders saw a flat tape. Long term investors saw a business leaning harder into artificial intelligence deployment and value based contracts while accepting near term margin pressure. The real headline from this earnings set is the margin and profit squeeze. Adjusted EBITDA margin sat at 13.3% and...

Why Teradata Stock Is Back In Focus After Its AI And Earnings Update Teradata (TDC) is back on investors’ radar after outlining its Teradata 3.0 AI plan, launching its Autonomous Knowledge Platform and related tools, and raising full year earnings guidance alongside stronger recent financial results. See our latest analysis for Teradata. At a share price of US$26.74, Teradata has seen short term share price weakness, with the 30 day share price return down 21.26% and the 90 day share price...

CCC Intelligent Solutions Holdings (CCC) stock is back in focus after the company released second quarter 2026 results alongside fresh revenue guidance for the third quarter and full year. See our latest analysis for CCC Intelligent Solutions Holdings. CCC Intelligent Solutions Holdings shares have picked up momentum around the latest earnings and guidance, with a 30-day share price return of 11.88% and a 90-day share price return of 64.39%, although the 1-year total shareholder return is...